Published Date: 04 Mar 2023
Karnataka: Karnataka Examination Authority (KEA) yog PG AYUSH ...
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on FcRn-blocking therapies in neurology!
Andrea Rossetti, MD, director of the EEG/Epilepsy Unit at the Department of Clinical Neurosciences the Lausanne University Hospital in Switzerland, offers insight into post-resuscitation epilepsy care.
Here's some of what is coming soon to NeurologyLive® this week.
Orelabrutinib Achieves Primary Endpoint in Phase 2b SLE Trial
Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal
Phase 3 VALIANT Results for Pegcetacoplan In C3G, IC-MPGN, With Andrew Bomback, MD
Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible
1.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
2.
Video: Liver transplant for patients with advanced colorectal cancer
3.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
4.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
5.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
1.
Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics
2.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
3.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
4.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation